M&A Deal Summary

ICL Group Acquires Lavie Bio

On April 21, 2025, ICL Group acquired life science company Lavie Bio from Evogene

Acquisition Highlights
  • This is ICL Group’s 1st transaction in the Life Science sector.
  • This is ICL Group’s 1st transaction in Israel.

M&A Deal Summary

Date 2025-04-21
Target Lavie Bio
Sector Life Science
Buyer(s) ICL Group
Sellers(s) Evogene
Deal Type Divestiture

Target

Lavie Bio

Rehovot, Israel
Lavie Bio is a provider in the ag-biologicals industry with a robust pipeline of microbiome-based ag-biological products. Lavie Bio was founded in 2019 and is based in Rehovot, Israel.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ICL Group

Tel Aviv, Israel

Category Company
Founded 1968
Sector Chemicals
Employees12,000
Revenue 6.8B USD (2024)
DESCRIPTION

ICL Group is a manufacturer of products based on specialty minerals that fulfill humanity's essential needs primarily in three markets: agriculture, food and engineered materials. ICL Group was founded in 1968 and is based in Tel Aviv, Israel.


DEAL STATS #
Overall 7 of 7
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 3 of 3
Country: Israel M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-02-28 Nitro 1000

Paraná, Brazil

Nitro 1000 is a manufacturer, developer and provider of biologicals in Brazil. Nitro 1000’s products are mainly aimed at soybean, corn and sugar cane crops, and their application replaces or optimizes the use of fertilizers. This not only helps farmers increase profitability, it also offers a more sustainable solution. Nitro 1000 was founded in 2007 and is based in Paraná , Brazil.

Buy $30M

Seller(S) 1

SELLER

Evogene

Rehovot, Israel

Category Company
Founded 1999
Sector Life Science
Employees117
Revenue 9M USD (2024)
DESCRIPTION

Evogene is a computational biology company aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost. Evogene was founded in 1999 and is headquartered in Rehovot, Israel.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Israel M&A 1 of 1
Year: 2025 M&A 1 of 1